...
search icon
slno-img

Soleno Therapeutics Inc Share Price

SLNO
NAQ
$39.41
+$0.8
(2.07%)
1D
Industry: Biotechnology Sector: Health Care

Soleno Therapeutics Inc Analyst Forecast

Soleno Therapeutics Inc Share Price Chart

Soleno Therapeutics Inc Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.07B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
599.09K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-3.18
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$36.67 L
$90.32 H
$39.41

About Soleno Therapeutics Inc, Common Stock

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California. more

Industry: BiotechnologySector: Health Care

Soleno Therapeutics Inc Stock Returns

Time FrameSLNOSectorS&P500
1-Week Return2.02%1.07%0.74%
1-Month Return-9.88%1.46%1.28%
3-Month Return-16.15%3.51%3.6%
6-Month Return-41.01%15.29%7.31%
1-Year Return-17%7.7%11.97%
3-Year Return1996.28%21.02%72.07%
5-Year Return-13.29%37.81%76.01%
10-Year Return-56.57%139.15%258.47%

Soleno Therapeutics Inc Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue2.19M2.21M2.21M1.96M1.99M[{"date":"2020-12-31","value":99.28,"profit":true},{"date":"2021-12-31","value":99.86,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.6,"profit":true},{"date":"2024-12-31","value":89.91,"profit":true}]
Gross Profit(2.19M)(2.21M)(2.21M)(1.96M)(1.99M)[{"date":"2020-12-31","value":-219400000,"profit":false},{"date":"2021-12-31","value":-220700000,"profit":false},{"date":"2022-12-31","value":-221000000,"profit":false},{"date":"2023-12-31","value":-195800000,"profit":false},{"date":"2024-12-31","value":-198700000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses29.75M31.53M24.40M41.38M187.67M[{"date":"2020-12-31","value":15.85,"profit":true},{"date":"2021-12-31","value":16.8,"profit":true},{"date":"2022-12-31","value":13,"profit":true},{"date":"2023-12-31","value":22.05,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Income(31.95M)(31.53M)(24.40M)(41.38M)(187.67M)[{"date":"2020-12-31","value":-3194900000,"profit":false},{"date":"2021-12-31","value":-3152800000,"profit":false},{"date":"2022-12-31","value":-2439700000,"profit":false},{"date":"2023-12-31","value":-4138400000,"profit":false},{"date":"2024-12-31","value":-18767100000,"profit":false}]
Total Non-Operating Income/Expense7.32M728.00K630.00K2.96M23.64M[{"date":"2020-12-31","value":30.97,"profit":true},{"date":"2021-12-31","value":3.08,"profit":true},{"date":"2022-12-31","value":2.66,"profit":true},{"date":"2023-12-31","value":12.5,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(24.64M)(30.91M)(24.07M)(38.99M)(175.85M)[{"date":"2020-12-31","value":-2463900000,"profit":false},{"date":"2021-12-31","value":-3091000000,"profit":false},{"date":"2022-12-31","value":-2406700000,"profit":false},{"date":"2023-12-31","value":-3898800000,"profit":false},{"date":"2024-12-31","value":-17585000000,"profit":false}]
Income Taxes(9.26M)(1.35M)(3.75M)2.71M(175.85M)[{"date":"2020-12-31","value":-341.34,"profit":false},{"date":"2021-12-31","value":-49.71,"profit":false},{"date":"2022-12-31","value":-138.1,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-6479.37,"profit":false}]
Income After Taxes(15.38M)(29.56M)(20.32M)(41.70M)-[{"date":"2020-12-31","value":null,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(24.64M)(30.91M)(24.07M)(33.18M)(175.85M)[{"date":"2020-12-31","value":-2463900000,"profit":false},{"date":"2021-12-31","value":-3091000000,"profit":false},{"date":"2022-12-31","value":-2406700000,"profit":false},{"date":"2023-12-31","value":-3317800000,"profit":false},{"date":"2024-12-31","value":-17585000000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(24.64M)(30.91M)(24.07M)(38.99M)(175.85M)[{"date":"2020-12-31","value":-2463900000,"profit":false},{"date":"2021-12-31","value":-3091000000,"profit":false},{"date":"2022-12-31","value":-2406700000,"profit":false},{"date":"2023-12-31","value":-3898800000,"profit":false},{"date":"2024-12-31","value":-17585000000,"profit":false}]
EPS (Diluted)(6.60)(5.85)(3.32)(2.97)(4.26)[{"date":"2020-12-31","value":-660,"profit":false},{"date":"2021-12-31","value":-585,"profit":false},{"date":"2022-12-31","value":-332,"profit":false},{"date":"2023-12-31","value":-297,"profit":false},{"date":"2024-12-31","value":-426,"profit":false}]

Soleno Therapeutics Inc Ratios

Soleno Therapeutics Inc Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SLNO
Cash Ratio 15.00
Current Ratio 16.08
Quick Ratio 15.88

Soleno Therapeutics Inc Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SLNO
ROA (LTM) -11.75%
ROE (LTM) -20.66%

Soleno Therapeutics Inc Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SLNO
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Soleno Therapeutics Inc Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SLNO
Trailing PE NM
Forward PE 7.27
P/S (TTM) 20.96
P/B 4.04
Price/FCF 47
EV/R 15.75
EV/Ebitda 0.02
PEG NM

FAQs

What is Soleno Therapeutics Inc share price today?

Soleno Therapeutics Inc (SLNO) share price today is $39.41

Can Indians buy Soleno Therapeutics Inc shares?

Yes, Indians can buy shares of Soleno Therapeutics Inc (SLNO) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SLNO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Soleno Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Soleno Therapeutics Inc (SLNO) via the Vested app. You can start investing in Soleno Therapeutics Inc (SLNO) with a minimum investment of $1.

How to invest in Soleno Therapeutics Inc shares from India?

You can invest in shares of Soleno Therapeutics Inc (SLNO) via Vested in three simple steps:

  • Click on Sign Up or Invest in SLNO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Soleno Therapeutics Inc shares
What is Soleno Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Soleno Therapeutics Inc (SLNO) is $90.32. The 52-week low price of Soleno Therapeutics Inc (SLNO) is $36.67.

What is Soleno Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Soleno Therapeutics Inc (SLNO) is

What is Soleno Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Soleno Therapeutics Inc (SLNO) is 4.04

What is Soleno Therapeutics Inc dividend yield?

The dividend yield of Soleno Therapeutics Inc (SLNO) is 0.00%

What is the Market Cap of Soleno Therapeutics Inc?

The market capitalization of Soleno Therapeutics Inc (SLNO) is $2.07B

What is Soleno Therapeutics Inc's stock symbol?

The stock symbol (or ticker) of Soleno Therapeutics Inc is SLNO

How Can Investors Use Soleno Therapeutics Inc Share Price Data for Long-Term Investment Decisions?

Consider the share price of Soleno Therapeutics Inc as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Soleno Therapeutics Inc has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Soleno Therapeutics Inc shares for Indian investors?

When investing in Soleno Therapeutics Inc shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Soleno Therapeutics Inc stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Soleno Therapeutics Inc share price with other stocks in the same sector?

Rather than merely checking the share price of Soleno Therapeutics Inc and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Soleno Therapeutics Inc stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top